Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

BACKGROUND: Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. METHODS: We conducted a multicenter, randomized, open-label, three-group, controlled trial involving...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalcanti, Alexandre B., Zampieri, Fernando G., Rosa, Regis G., Azevedo, Luciano C.P., Veiga, Viviane C., Avezum, Alvaro, Damiani, Lucas P., Marcadenti, Aline, Kawano-Dourado, Letícia, Lisboa, Thiago, Junqueira, Debora L. M., de Barros e Silva, Pedro G.M., Tramujas, Lucas, Abreu-Silva, Erlon O., Laranjeira, Ligia N., Soares, Aline T., Echenique, Leandro S., Pereira, Adriano J., Freitas, Flávio G.R., Gebara, Otávio C.E., Dantas, Vicente C.S., Furtado, Remo H.M., Milan, Eveline P., Golin, Nicole A., Cardoso, Fábio F., Maia, Israel S., Hoffmann Filho, Conrado R., Kormann, Adrian P.M., Amazonas, Roberto B., Bocchi de Oliveira, Monalisa F., Serpa-Neto, Ary, Falavigna, Maicon, Lopes, Renato D., Machado, Flávia R., Berwanger, Otavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397242/
https://www.ncbi.nlm.nih.gov/pubmed/32706953
http://dx.doi.org/10.1056/NEJMoa2019014

Ejemplares similares

Ejemplares similares